Ranibizumab Versus Aflibercept for CRVO in Young Patients.

NCT05282420 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Non-Ischemic Central Retinal Vein Occlusion With Macular Edema

Interventions

PROCEDURE: intravitreal injection of Ranibizumab
PROCEDURE: intravitreal injection of Aflipercept
DRUG: Ranibizumab
DRUG: Aflibercept

Sponsor

South Valley University